“Preventing overtreatment of breast cancer precursors” Since the introduction of screening strategies, the incidence of Ductal Carcinoma In Situ (DCIS) has increased manifold, without a decrease in the incidence of advanced stages of breast cancer. This suggests that many DCIS lesions are detected that would have never caused any clinical symptoms if screening would have been omitted. This so-called overdiagnosis results in overtreatment, as we cannot distinguish yet which DCIS lesions are har
November 7-8, 2018
The Netherlands Cancer Institute – Antoni van LeeuwenhoekConference Room Z4Plesmanlaan 1211066 CX Amsterdam, The Netherlands